http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3071151-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931f224df2a0741aee32a88d433e80ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23e9198a7b00d4f50beb93b2d42e533d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-15 |
| filingDate | 2018-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090254b55c7dae0c4e7d65fe3669ab39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da67b6834526a12bd4c97c0f3af13ef8 |
| publicationDate | 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-3071151-A1 |
| titleOfInvention | FIBRINOGEN-THROMBINE BIOREACTOR THAT TRANSFORMS BLOOD OF THE RULES OF WOMEN IN GEL |
| abstract | The present invention relates to a Fibrinogen-Thrombin Bioreactor. This bioreactor's role is to allow blood clotting of the rules of women. The blood of the rules is incoagulable because it does not contain fibrinogen which is the substrate of thrombin. More specifically, within this patent application, our bioreactor is a biological set consisting of a substrate (fibrinogen) and an enzyme (thrombin) allowing the transformation of a biological medium, the blood of the rules in our case, from one state to another, namely "sol-gel". Activation of the endogenous pathway by the "contact" factors, between the blood and the bioreactor, must be sufficient to transform the prothrombin contained in the blood into thrombin thus acting on fibrinogen, a component added within the bioreactor , to turn it into an insoluble molecule that is fibrin. The method according to the invention is particularly intended to be integrated within hygienic devices for protection during menstruation in order to significantly improve the comfort of women during menstruation since the blood of the rules will be transformed into gel. |
| priorityDate | 2017-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.